OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus

Leukemia Research

Volumn 33, Issue 12, 2009, Pages 1670-1677

  Våtsveen, Thea Kristin ^a,b   Tian, Erming ^a   Kresse, Stine H ^c   Meza Zepeda, Leonardo A ^c,d   Gabrea, Ana ^e   Glebov, Oleg ^e   Dai, Hong Yan ^b   Sundan, Anders ^a   Kuehl, W Michael ^e   Børset, Magne ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Array CGH; FISH; Hyperdiploid; IGK; MAFB; MYC

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; MYC PROTEIN; RNA; TRANSCRIPTION FACTOR MAFB;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 15; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE INSERTION; GENE LOCUS; GENE TRANSLOCATION; GENOTYPE; HUMAN; HUMAN CELL; HYPERDIPLOIDY; MULTIPLE MYELOMA; NUMERICAL CHROMOSOME ABERRATION; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; DIPLOIDY; ENHANCER ELEMENTS, GENETIC; GENES, MYC; GENOTYPE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MAFB TRANSCRIPTION FACTOR; MULTIPLE MYELOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSLOCATION, GENETIC;

EID: 70349177837     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.001     Document Type: Article

References (23)

1. Chng W.J., Glebov O., Bergsagel P.L., and Kuehl W.M. Genetic events in the pathogenesis of multiple myeloma. Best Pract Res Clin Haematol 20 December (4) (2007) 571-596
2. Fonseca R., Debes-Marun C.S., Picken E.B., Dewald G.W., Bryant S.C., Winkler J.M., et al. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. Blood 102 October (7) (2003) 2562-2567
3. Smadja N.V., Bastard C., Brigaudeau C., Leroux D., and Fruchart C. Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 98 October (7) (2001) 2229-2238
4. Gabrea A., Martelli M.L., Qi Y., Roschke A., Barlogie B., Shaughnessy Jr. J.D., et al. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors. Genes Chromosome Cancer 47 7 (2008 Jul) 573-590
5. Bergsagel P.L., and Kuehl W.M. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23 September (26) (2005) 6333-6338
6. Avet-Loiseau H., Daviet A., Brigaudeau C., Callet-Bauchu E., Terre C., Lafage-Pochitaloff M., et al. Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis. Blood 97 February (3) (2001) 822-825
7. Tiedemann R.E., Gonzalez-Paz N., Kyle R.A., Santana-Davila R., Price-Troska T., Van Wier S.A., et al. Genetic aberrations and survival in plasma cell leukemia. Leukemia 22 5 (2008) 1044-1052
8. Bergsagel P.L., Kuehl W.M., Zhan F., Sawyer J., Barlogie B., and Shaughnessy Jr. J. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106 July (1) (2005) 296-303
9. Chng W.J., and Fonseca R. Cell lines of hyperdiploid myeloma, are we there yet?. Br J Haematol 140 5 (2008) 579-580
10. Borset M., Waage A., Brekke O.L., and Helseth E. TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. Eur J Haematol 53 July (1) (1994) 31-37
11. Jackson N., Lowe J., Ball J., Bromidge E., Ling N.R., Larkins S., et al. Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2. Clin Exp Immunol 75 January (1) (1989) 93-99
12. Fagerli U.M., Holt R.U., Holien T., Vaatsveen T.K., Zhan F., Egeberg K.W., et al. Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood 111 January (2) (2008) 806-815
13. Ro T.B., Holt R.U., Brenne A.T., Hjorth-Hansen H., Waage A., Hjertner O., et al. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 23 April (17) (2004) 3024-3032
14. Sawyer J.R., Roloson G.J., Bell J.M., Thomas J.R., Teo C., and Chadduck W.M. Telomeric associations in the progression of chromosome aberrations in pediatric solid tumors. Cancer Genet Cytogenet 90 August (1) (1996) 1-13
15. Sawyer J.R., Lukacs J.L., Thomas E.L., Swanson C.M., Goosen L.S., Sammartino G., et al. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma. Br J Haematol 112 January (1) (2001) 167-174
16. Meza-Zepeda L.A., Kresse S.H., Barragan-Polania A.H., Bjerkehagen B., Ohnstad H.O., Namlos H.M., et al. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66 September (18) (2006) 8984-8993
17. Wang J., Meza-Zepeda L.A., Kresse S.H., and Myklebost O. M-CGH: analysing microarray-based CGH experiments. BMC Bioinformatics June (5) (2004) 74
18. Bergsagel P.L., Chesi M., Nardini E., Brents L.A., Kirby S.L., and Kuehl W.M. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93 24 (1996 Nov 26) 13931-13936
19. Zhan F., Huang Y., Colla S., Stewart J.P., Hanamura I., Gupta S., et al. The molecular classification of multiple myeloma. Blood 108 September (6) (2006) 2020-2028
20. Dib A., Peterson T.R., Raducha-Grace L., Zingone A., Zhan F., Hanamura I., et al. Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression. Cell Div 1 (2006) 23
21. Drexler H.G., and Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk Res 24 August (8) (2000) 681-703
22. Chng W.J., Kumar S., Vanwier S., Ahmann G., Price-Troska T., Henderson K., et al. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 67 April (7) (2007) 2982-2989
23. Li X., Pennisi A., Zhan F., Sawyer J.R., Shaughnessy J.D., and Yaccoby S. Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines. Br J Haematol 138 September (6) (2007) 802-811